APA (7th ed.) Citation

Ruifeng Tian, Jinjie Yang, Xiaoming Wang, Shuaiyang Liu, Ruixiang Dong, Zhenya Wang, . . . Xiao-Jing Zhang. (2023). Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome. BMC.

Chicago Style (17th ed.) Citation

Ruifeng Tian, et al. Honokiol Acts as an AMPK Complex Agonist Therapeutic in Non-alcoholic Fatty Liver Disease and Metabolic Syndrome. BMC, 2023.

MLA (9th ed.) Citation

Ruifeng Tian, et al. Honokiol Acts as an AMPK Complex Agonist Therapeutic in Non-alcoholic Fatty Liver Disease and Metabolic Syndrome. BMC, 2023.

Warning: These citations may not always be 100% accurate.